|
2015 Journal Article Centipede venom: Recent discoveries and current state of knowledgeUndheim, Eivind, Fry, Bryan and King, Glenn F (2015). Centipede venom: Recent discoveries and current state of knowledge. Toxins, 7 (3), 679-704. doi: 10.3390/toxins7030679 |
|
2015 Journal Article The cystine knot is responsible for the exceptional stability of the insecticidal spider toxin ω-Hexatoxin-Hv1aHerzig, Volker and King, Glenn F. (2015). The cystine knot is responsible for the exceptional stability of the insecticidal spider toxin ω-Hexatoxin-Hv1a. Toxins, 7 (10), 4366-4380. doi: 10.3390/toxins7104366 |
|
2015 Book Chapter PrefaceKing, Glenn (2015). Preface. Venoms to drugs: venom as a source for the development of human therapeutics. (pp. VII-IX) edited by Glenn F. King. Cambridge, United States: RSC. doi: 10.1039/9781849737876-FP007 |
|
2015 Book Chapter The Structural Universe of Disulfide-Rich Venom PeptidesLavergne, Vincent, Alewood, Paul F., Mobli, Mehdi and King, Glenn F. (2015). The Structural Universe of Disulfide-Rich Venom Peptides. Venoms to Drugs : Venom as a Source for the Development of Human Therapeutics. (pp. 37-79) edited by King, Glenn F.. London, United Kingdom: Royal Society of Chemistry. doi: 10.1039/9781849737876-00037 |
|
2015 Journal Article From foe to friend: using animal toxins to investigate ion channel functionKalia, Jeet, Milescu, Mirela, Salvatierra, Juan, Wagner, Jordan, Klint, Julie K., King, Glenn F., Olivera, Baldomero M. and Bosmans, Frank (2015). From foe to friend: using animal toxins to investigate ion channel function. Journal of Molecular Biology, 427 (1), 158-175. doi: 10.1016/j.jmb.2014.07.027 |
|
2015 Journal Article Mutations in the voltage-gated potassium channel gene KCNH1 cause Temple-Baraitser syndrome and epilepsySimons Cas, Rash, Lachlan D., Crawford, Joanna, Ma, Linlin, Cristofori-Armstrong, Ben, Miller, David, Ru, Kelin, Baillie, Gregory J., Alanay, Yasemin, Jacquinet, Adeline, Debray, François-Guillaume, Verloes, Alain, Shen, Joseph, Yesil, Gözde, Guler, Serhat, Yuksel, Adnan, Cleary, John G., Grimmond, Sean M., McGaughran, Julie, King, Glenn F., Gabbett, Michael T. and Taft, Ryan J. (2015). Mutations in the voltage-gated potassium channel gene KCNH1 cause Temple-Baraitser syndrome and epilepsy. Nature Genetics, 47 (1), 73-77. doi: 10.1038/ng.3153 |
|
2015 Book Chapter Therapeutic applications of spider-venom peptidesSmith, Jennifer J., Lau, Carus Ho Yee, Herzig, Volker, Ikonomopoulou, Maria P., Rash, Lachlan D. and King, Glenn F. (2015). Therapeutic applications of spider-venom peptides. Venoms to Drugs: Venom as a Source for the Development of Human Therapeutics. (pp. 221-244) edited by Glenn F. King. Cambridge, United Kingdom: Royal Society of Chemistry.. doi: 10.1039/9781849737876-00221 |
|
2015 Journal Article Safety and Efficacy of Tumor-Targeted Interleukin 12 Gene Therapy in Treated and Non-Treated, Metastatic LesionsCutrera, Jeffry, King, Glenn, Jones, Pamela, Kicenuik, Kristin, Gumpel, Elias, Xia, Xueqing and Li, Shulin (2015). Safety and Efficacy of Tumor-Targeted Interleukin 12 Gene Therapy in Treated and Non-Treated, Metastatic Lesions. Current Gene Therapy, 15 (1), 44-54. |
|
2015 Conference Publication Harnessing animal venoms in the discovery of potent Nav inhibitors through fluorescent and automated patch clamp assaysCardoso, Fernanda Caldas , Herzig, Volker , King, Glenn F. and Lewis, Richard J. (2015). Harnessing animal venoms in the discovery of potent Nav inhibitors through fluorescent and automated patch clamp assays. 18th World Congress of the International Society on Toxinology, Oxford UK, 25-30 September 2015. |
|
2015 Book Chapter Does nature do ion channel drug discovery better than us?Lewis, Richard J., Vetter, Irina, Cardoso, Fernanda C., Inserra, Marco and King, Glenn (2015). Does nature do ion channel drug discovery better than us?. Ion channel drug discovery. (pp. 297-313) edited by Brian Cox and Martin Gosling. Cambridge, United Kingdom: Royal Society of Chemistry. doi: 10.1039/9781849735087-00297 |
|
2015 Conference Publication Rational development of novel analgesics for the treatment of chronic pain: Structure-Function studies of an engineered Nav1.7 blockerRahnama, S., Lachlan, R., Cardoso, F. C., Smith, J., Deuis, J., Vetter, I., King, G. F. and Mobli, M. (2015). Rational development of novel analgesics for the treatment of chronic pain: Structure-Function studies of an engineered Nav1.7 blocker. The 40th Lorne Conference on Protein Structure and Function, Lorne VIC, Australia, 8-12 February 2015. |
|
2015 Book Venoms to Drugs: Venom as a Source for the Development of Human TherapeuticsKing, Glenn F. ed. (2015). Venoms to Drugs: Venom as a Source for the Development of Human Therapeutics. RSC Drug Discovery Series, Cambridge, United Kingdom: Royal Society of Chemistry. doi: 10.1039/9781849737876 |
|
2015 Book Chapter Venoms-Based Drug Discovery: Proteomic and Transcriptomic ApproachesDutertre, Sebastien, Undheim, Eivind, Pineda, Sandy S., Jin, Ai-Hua (Jean), Lavergne, Vincent, Fry, Bryan G., Lewis, Richard J., Alewood, Paul F. and King, Glenn F. (2015). Venoms-Based Drug Discovery: Proteomic and Transcriptomic Approaches. Venoms to Drugs. (pp. 80-96) edited by King, Glenn F. London, United Kingdom: Royal Society of Chemistry. doi: 10.1039/9781849737876-00080 |
|
2014 Journal Article Construction of a hypervirulent and specific mycoinsecticide for locust controlFang, Weiguo, Lu, Hsiao-Ling, King, Glenn F and St. Leger, Raymond J. (2014). Construction of a hypervirulent and specific mycoinsecticide for locust control. Scientific Reports, 4 (1) 7345, 7345.1-7345.6. doi: 10.1038/srep07345 |
|
2014 Journal Article No gain, no pain: NaV1.7 as an analgesic targetKing, Glenn F and Vetter, Irina (2014). No gain, no pain: NaV1.7 as an analgesic target. ACS Chemical Neuroscience, Articles ASAP (9), 749-751. doi: 10.1021/cn500171p |
|
2014 Journal Article Clawing through evolution: toxin diversification and convergence in the ancient lineage Chilopoda (Centipedes)Undheim, Eivind, Jones, Alun, Clauser, Karl R., Holland, John W., Pineda Gonzalez, Sandy, King, Glenn F and Bryan Fry (2014). Clawing through evolution: toxin diversification and convergence in the ancient lineage Chilopoda (Centipedes). Molecular Biology and Evolution, 31 (8), 2124-2148. doi: 10.1093/molbev/msu162 |
|
2014 Journal Article A distinct sodium channel voltage-sensor locus determines insect selectivity of the spider toxin Dc1aBende, Niraj S., Dziemborowicz, Sławomir, Mobli, Mehdi, Herzig, Volker, Gilchrist, John, Wagner, Jordan, Nicholson, Graham M., King, Glenn F and Bosmans, Frank (2014). A distinct sodium channel voltage-sensor locus determines insect selectivity of the spider toxin Dc1a. Nature Communications, 5 (1) 4350, 4350. doi: 10.1038/ncomms5350 |
|
2014 Journal Article Isolation, synthesis and characterization of omega-TRTX-Cc1a, a novel tarantula venom peptide that selectively targets L-type CaV channelsKlint, Julie K., Berecki, Géza, Durek, Thomas, Mobli, Mehdi, Knapp, Oliver, King, Glenn F., Adams, David J., Alewood, Paul F. and Rash, Lachlan D. (2014). Isolation, synthesis and characterization of omega-TRTX-Cc1a, a novel tarantula venom peptide that selectively targets L-type CaV channels. Biochemical Pharmacology, 89 (2), 276-286. doi: 10.1016/j.bcp.2014.02.008 |
|
2014 Journal Article Multifunctional warheads: diversification of the toxin arsenal of centipedes via novel multidomain transcriptsUndheim, Eivind A. B., Sunagar, Kartik, Hamilton, Brett R., Jones, Alun, Venter, Deon J., Fry, Bryan G. and King, Glenn F. (2014). Multifunctional warheads: diversification of the toxin arsenal of centipedes via novel multidomain transcripts. Journal of Proteomics, 102, 1-10. doi: 10.1016/j.jprot.2014.02.024 |
|
2014 Journal Article Functional implications of large backbone amplitude motions of the glycoprotein 130-binding epitope of interleukin-6Bobby, Romel, Robustelli, Paul, Kralicek, Andrew V., Mobli, Mehdi, King, Glenn F., Grotzinger, Joachim and Dingley, Andrew J. (2014). Functional implications of large backbone amplitude motions of the glycoprotein 130-binding epitope of interleukin-6. FEBS Journal, 281 (10), 2471-2483. doi: 10.1111/febs.12800 |
